- Phone
-
Address
Qinhuangdao Economic and Technological Development Zone
Product Categories
Qinhuangdao Shangben Medical Equipment Technology Co., Ltd
Early identification tool for dementia
NegotiableUpdate on 06/26
- Model
- Nature of the Manufacturer
- Producers
- Product Category
- Place of Origin
Overview
The ADDS dementia early recognition tool uses a combination of graphic drawing parallel coordinate maps and radar maps to visualize and quantify EEG and behavioral control. Through real-time recording and point distribution calculation of the graphic drawing process, as well as variable scale singular value analysis and calculation of EEG physiological parameters in the time-frequency domain, it achieves the diagnosis and early risk assessment of Alzheimer's disease!
Product Details
Product registration name: Early cognitive function screening device
Product nickname:ADDSEarly identification tool for dementia
Wheatstone ADDS cognitive function early screening device, as a professionalEarly identification tool for dementiaInnovatively integrating internationally recognized cognitive scales with dynamic electroencephalography (EEG) monitoring technology, breaking through the industry pain points of traditional screening with strong subjectivity and low early recognition rates. thatEarly screening equipment for Alzheimer's diseaseThrough non-invasive EEG acquisition and AI algorithm analysis, precise capture of clinical latency brain function abnormalities in cognitive impairment is achieved, providing quantitative data support for "early detection, early diagnosis, and early intervention", which deeply conforms to the core requirements of the "Chinese Alzheimer's Disease Dementia Diagnosis and Treatment Guidelines (2025 Edition)" and is the core of constructing a cognitive impairment prevention and treatment system for medical institutions at all levelsCognitive function testing instrument.
Core technological advantages
1. Dual dimensional precise evaluation system (core guarantee for early identification of dementia)
Integrate international standard scales such as MMSE, MOCA, ADL, and synchronously collect behavioral data such as memory, attention, and executive function;
By combining dynamic electroencephalogram monitoring, non-linear feature quantities of EEG signals such as alpha waves, beta waves, and theta waves are extracted, and the maximum scale is varied The most relevantImplementing multi-dimensional integrated analysis with small redundancy algorithm;
Compared to traditional single scale evaluation, the error rate has been reduced by 60%Early screening for cognitive impairmentProvide reliable data support.
2. Efficient and convenient operation experience (suitable for large-scale dementia screening scenarios)
Non invasive design, no need for blood draw or fasting, wearing a lightweight EEG collector can complete the detection, with high acceptance among elderly patients;
Touch based human-computer interaction, one click start operation, real-time display of detection status on LED LCD screen, basic medical staff can get started after simple training;
Quickly complete screening in 10-15 minutes, generate quantitative evaluation reports in real-time, and adapt to grassroots units such as communities and townshipsLarge scale cognitive health screeningRequirement.
3. Full scenario data support capability (empowering the entire process of dementia diagnosis and treatment)
The report covers cognitive domain scores, abnormal indicator labeling, risk level assessment, and personalized intervention recommendations, supporting long-term follow-up data tracking of patients and assisting inMonitoring of cognitive impairment；
Detecting data, providing multidimensional datasets for clinical research, and assisting academic research and technological iteration related to cognitive impairment;
The security level reaches Class I BF type application part, which complies with medical equipment safety standards and is suitable for multiple scenarios such as tertiary hospitals, mental health centers, and physical examination centersEarly identification of dementiaRequirement.
Scope of application
Core applicable population
Routine screening of cognitive health in the elderly population aged 60 and above (with emphasis on)Screening of high-risk populations for dementia）；
Individuals with suspected symptoms such as memory loss, visual spatial impairment, and decreased executive ability（Early detection of cognitive dysfunction）；
Monitoring of disease progression and evaluation of intervention effectiveness in patients with cognitive impairment（Cognitive function rehabilitation tracking）.
Main application scenarios
Third class hospitals: neurology, geriatrics, psychiatry, clinical diagnosis and differential diagnosis（Accurate early identification of dementia）；
Primary healthcare: large-scale screening of community health service centers and township health centers（Group cognitive health screening）；
Professional institutions: Mental Health Centers, Rehabilitation Hospitals, Patient Grading Management（Classification assessment of cognitive impairment）；
Health Management: Special Assessment of Cognitive Health in Physical Examination Centers and Elderly Care Communities（Health management cognitive screening）.
Similar Product Recommend
